{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T23:12:52Z","timestamp":1774307572969,"version":"3.50.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T00:00:00Z","timestamp":1738022400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T00:00:00Z","timestamp":1738022400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"DOI":"10.1007\/s00403-025-03801-2","type":"journal-article","created":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T15:00:39Z","timestamp":1738076439000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Study of cathelicidin (LL-37) immunoexpression in the skin of vitiligo patients"],"prefix":"10.1007","volume":"317","author":[{"given":"Lamia Hamouda","family":"Elgarhy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Basma Ramadan Refaey","family":"Ramadan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fersan Abd Allah","family":"Sallam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dalya Ayman","family":"Iskandarani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"El-Sayed Shaaban","family":"Hewedy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,1,28]]},"reference":[{"key":"3801_CR1","doi-asserted-by":"publisher","first-page":"143","DOI":"10.4103\/0970-0218.137150","volume":"39","author":"RV Vora","year":"2014","unstructured":"Vora RV, Patel BB, Chaudhary AH, Mehta MJ, Pilani AP (2014) A clinical study of Vitiligo in a rural set up of Gujarat. Indian J Community Med 39:143\u2013146","journal-title":"Indian J Community Med"},{"key":"3801_CR2","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1111\/j.1365-4632.2011.05377.x","volume":"51","author":"C Kr\u00fcger","year":"2012","unstructured":"Kr\u00fcger C, Schallreuter KU (2012) A review of the worldwide prevalence of vitiligo in children\/adolescents and adults. Int J Dermatol 51:1206\u20131212","journal-title":"Int J Dermatol"},{"key":"3801_CR3","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1046\/j.1365-4362.2003.01936.x","volume":"42","author":"K Abdel-Hafez","year":"2003","unstructured":"Abdel-Hafez K, Abdel-Aty MA, Hofny ER (2003) Prevalence of skin diseases in rural areas of Assiut Governorate, Upper Egypt. Int J Dermatol 42:887\u2013892","journal-title":"Int J Dermatol"},{"key":"3801_CR4","doi-asserted-by":"publisher","first-page":"180","DOI":"10.4103\/0019-5154.80413","volume":"56","author":"JJ Nordlund","year":"2011","unstructured":"Nordlund JJ (2011) Vitiligo: a review of some facts lesser known about depigmentation. Indian J Dermatol 56:180\u2013189","journal-title":"Indian J Dermatol"},{"key":"3801_CR5","first-page":"3617","volume":"20","author":"M Lv","year":"2019","unstructured":"Lv M, Li Z, Liu J, Lin F, Zhang Q, Li Z et al (2019) MicroRNA\u2013155 inhibits the proliferation of CD8\u2009+\u2009T cells via upregulating regulatory T cells in vitiligo. Mol Med Rep 20:3617\u20133624","journal-title":"Mol Med Rep"},{"key":"3801_CR6","doi-asserted-by":"crossref","unstructured":"Le Poole IC, Wa\u00f1kowicz-Kali\u00f1ska A, van den Wijngaard RM, Nickoloff BJ, Das PK (2004) Autoimmune aspects of depigmentation in vitiligo. J Investig Dermatol Symp Proc.;9:68\u201372","DOI":"10.1111\/j.1087-0024.2004.00825.x"},{"key":"3801_CR7","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1002\/biof.1225","volume":"41","author":"K Bandurska","year":"2015","unstructured":"Bandurska K, Berdowska A, Barczy\u0144ska-Felusiak R, Krupa P (2015) Unique features of human cathelicidin LL-37. BioFactors 41:289\u2013300","journal-title":"BioFactors"},{"key":"3801_CR8","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1177\/0961203311398515","volume":"20","author":"CL Sun","year":"2011","unstructured":"Sun CL, Zhang FZ, Li P, Bi LQ (2011) LL-37 expression in the skin in systemic lupus erythematosus. Lupus 20:904\u2013911","journal-title":"Lupus"},{"key":"3801_CR9","doi-asserted-by":"publisher","first-page":"268257","DOI":"10.1155\/2014\/268257","volume":"2014","author":"YJ Hwang","year":"2014","unstructured":"Hwang YJ, Jung HJ, Kim MJ, Roh NK, Jung JW, Lee YW et al (2014) Serum levels of LL-37 and inflammatory cytokines in plaque and guttate psoriasis. Mediators Inflamm 2014:268257","journal-title":"Mediators Inflamm"},{"key":"3801_CR10","doi-asserted-by":"publisher","first-page":"251","DOI":"10.4062\/biomolther.2013.058","volume":"21","author":"K Park","year":"2013","unstructured":"Park K, Lee S, Lee YM (2013) Sphingolipids and antimicrobial peptides: function and roles in atopic dermatitis. Biomol Ther (Seoul) 21:251\u2013257","journal-title":"Biomol Ther (Seoul)"},{"key":"3801_CR11","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1111\/j.1755-148X.2011.00838.x","volume":"24","author":"N van Geel","year":"2011","unstructured":"van Geel N, Speeckaert R, Taieb A, Picardo M, B\u00f6hm M, Gawkrodger DJ et al (2011) Koebner\u2019s phenomenon in vitiligo: European position paper. Pigment Cell Melanoma Res 24:564\u2013573","journal-title":"Pigment Cell Melanoma Res"},{"key":"3801_CR12","doi-asserted-by":"publisher","first-page":"315","DOI":"10.4103\/0378-6323.26722","volume":"72","author":"U Bhor","year":"2006","unstructured":"Bhor U, Pande S (2006) Scoring systems in dermatology. Indian J Dermatol Venereol Leprol 72:315\u2013321","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"3801_CR13","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1111\/bjd.13432","volume":"172","author":"L Komen","year":"2015","unstructured":"Komen L, da Gra\u00e7a V, Wolkerstorfer A, de Rie MA, Terwee CB, van der Veen JP (2015) Vitiligo Area Scoring Index and Vitiligo European Task Force assessment: reliable and responsive instruments to measure the degree of depigmentation in vitiligo. Br J Dermatol 172:437\u2013443","journal-title":"Br J Dermatol"},{"key":"3801_CR14","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1111\/j.1365-2133.2009.09095.x","volume":"161","author":"N Ballardini","year":"2009","unstructured":"Ballardini N, Johansson C, Lilja G, Lindh M, Linde Y, Scheynius A et al (2009) Enhanced expression of the antimicrobial peptide LL-37 in lesional skin of adults with atopic eczema. Br J Dermatol 161:40\u201347","journal-title":"Br J Dermatol"},{"key":"3801_CR15","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1016\/j.jaad.2018.11.047","volume":"80","author":"IA Vallerand","year":"2019","unstructured":"Vallerand IA, Lewinson RT, Parsons LM, Hardin J, Haber RM, Lowerison MW et al (2019) Vitiligo and major depressive disorder: a bidirectional population-based cohort study. J Am Acad Dermatol 80:1371\u20131379","journal-title":"J Am Acad Dermatol"},{"key":"3801_CR16","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s13555-017-0176-3","volume":"7","author":"S Thibaut de M\u00e9nonville","year":"2017","unstructured":"Thibaut de M\u00e9nonville S, Rosignoli C, Soares E, Roquet M, Bertino B, Chappuis JP et al (2017) Topical Treatment of Rosacea with Ivermectin inhibits Gene expression of Cathelicidin Innate Immune Mediators, LL-37 and KLK5, in reconstructed and Ex vivo skin models. Dermatol Ther (Heidelb) 7:213\u2013225","journal-title":"Dermatol Ther (Heidelb)"},{"key":"3801_CR17","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.3349\/ymj.2014.55.6.1648","volume":"55","author":"JY Kim","year":"2014","unstructured":"Kim JY, Kim YJ, Lim BJ, Sohn HJ, Shin D, Oh SH (2014) Increased expression of cathelicidin by direct activation of protease-activated receptor 2: possible implications on the pathogenesis of rosacea. Yonsei Med J 55:1648\u20131655","journal-title":"Yonsei Med J"},{"key":"3801_CR18","doi-asserted-by":"publisher","first-page":"5621","DOI":"10.1038\/ncomms6621","volume":"5","author":"R Lande","year":"2014","unstructured":"Lande R, Botti E, Jandus C, Dojcinovic D, Fanelli G, Conrad C et al (2014) The antimicrobial peptide LL37 is a T-cell autoantigen in psoriasis. Nat Commun 5:5621","journal-title":"Nat Commun"},{"key":"3801_CR19","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1111\/exd.14200","volume":"29","author":"F Atazadeh","year":"2020","unstructured":"Atazadeh F, Fazeli Z, Vahidnezhad H, Namazi N, Younespour S, Youssefian L et al (2020) Increased level of cathelicidin (LL-37) in vitiligo: possible pathway independent from vitamin D receptor gene polymorphism. Exp Dermatol 29:1176\u20131185","journal-title":"Exp Dermatol"},{"key":"3801_CR20","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1038\/jid.2014.143","volume":"134","author":"C Kiatsurayanon","year":"2014","unstructured":"Kiatsurayanon C, Niyonsaba F, Smithrithee R, Akiyama T, Ushio H, Hara M et al (2014) Host defense (Antimicrobial) peptide, human \u03b2-defensin-3, improves the function of the epithelial tight-junction barrier in human keratinocytes. J Invest Dermatol 134:2163\u20132173","journal-title":"J Invest Dermatol"},{"key":"3801_CR21","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1159\/000362789","volume":"6","author":"T Akiyama","year":"2014","unstructured":"Akiyama T, Niyonsaba F, Kiatsurayanon C, Nguyen TT, Ushio H, Fujimura T et al (2014) The human cathelicidin LL-37 host defense peptide upregulates tight junction-related proteins and increases human epidermal keratinocyte barrier function. J Innate Immun 6:739\u2013753","journal-title":"J Innate Immun"},{"key":"3801_CR22","doi-asserted-by":"crossref","unstructured":"Jiang Y, Tsoi LC, Billi AC, Ward NL, Harms PW, Zeng C et al (2020) Cytokinocytes: the diverse contribution of keratinocytes to immune responses in skin. JCI Insight.;5","DOI":"10.1172\/jci.insight.142067"},{"key":"3801_CR23","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.3389\/fimmu.2019.01440","volume":"10","author":"LJ Zhang","year":"2019","unstructured":"Zhang LJ (2019) Type1 interferons potential initiating factors linking skin wounds with Psoriasis Pathogenesis. Front Immunol 10:1440","journal-title":"Front Immunol"},{"key":"3801_CR24","doi-asserted-by":"crossref","unstructured":"Yang G, Seok JK, Kang HC, Cho YY, Lee HS, Lee JY (2020) Skin barrier abnormalities and Immune Dysfunction in atopic dermatitis. Int J Mol Sci.;21","DOI":"10.3390\/ijms21082867"},{"key":"3801_CR25","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.jid.2016.09.016","volume":"137","author":"JM Richmond","year":"2017","unstructured":"Richmond JM, Bangari DS, Essien KI, Currimbhoy SD, Groom JR, Pandya AG et al (2017) Keratinocyte-derived chemokines orchestrate T-Cell positioning in the Epidermis during Vitiligo and May serve as biomarkers of Disease. J Invest Dermatol 137:350\u2013358","journal-title":"J Invest Dermatol"},{"key":"3801_CR26","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1084\/jem.20061308","volume":"203","author":"SC Liang","year":"2006","unstructured":"Liang SC, Tan XY, Luxenberg DP, Karim R, Dunussi-Joannopoulos K, Collins M et al (2006) Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J Exp Med 203:2271\u20132279","journal-title":"J Exp Med"},{"issue":"3","key":"3801_CR27","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1034\/j.1600-0749.2003.00032.x","volume":"16","author":"A Alkhateeb","year":"2003","unstructured":"Alkhateeb A et al (2003) Epidemiology of vitiligo and associated autoimmune diseases in caucasian probands and their families. Pigment Cell Res 16(3):208\u2013214","journal-title":"Pigment Cell Res"},{"key":"3801_CR28","doi-asserted-by":"crossref","unstructured":"Manga P, Elbuluk N, Orlow SJ (2016) Recent advances in understanding vitiligo. F1000Res.;5","DOI":"10.12688\/f1000research.8976.1"},{"key":"3801_CR29","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.immuni.2016.06.021","volume":"45","author":"LJ Zhang","year":"2016","unstructured":"Zhang LJ, Sen GL, Ward NL, Johnston A, Chun K, Chen Y et al (2016) Antimicrobial peptide LL37 and MAVS Signaling Drive Interferon-\u03b2 production by epidermal keratinocytes during skin Injury. Immunity 45:119\u2013130","journal-title":"Immunity"},{"key":"3801_CR30","doi-asserted-by":"publisher","first-page":"eabb5274","DOI":"10.1126\/sciadv.abb5274","volume":"6","author":"H Liang","year":"2020","unstructured":"Liang H, Yan Y, Wu J, Ge X, Wei L, Liu L et al (2020) Topical nanoparticles interfering with the DNA-LL37 complex to alleviate psoriatic inflammation in mice and monkeys. Sci Adv 6:eabb5274","journal-title":"Sci Adv"},{"key":"3801_CR31","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1146\/annurev-immunol-100919-023531","volume":"38","author":"ML Frisoli","year":"2020","unstructured":"Frisoli ML, Essien K, Harris JE (2020) Vitiligo: mechanisms of Pathogenesis and treatment. Annu Rev Immunol 38:621\u2013648","journal-title":"Annu Rev Immunol"},{"key":"3801_CR32","doi-asserted-by":"publisher","first-page":"649","DOI":"10.3346\/jkms.2005.20.4.649","volume":"20","author":"JE Kim","year":"2005","unstructured":"Kim JE, Kim BJ, Jeong MS, Seo SJ, Kim MN, Hong CK et al (2005) Expression and modulation of LL-37 in normal human keratinocytes, HaCaT cells, and inflammatory skin diseases. J Korean Med Sci 20:649\u2013654","journal-title":"J Korean Med Sci"},{"issue":"1","key":"3801_CR33","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1080\/09546634.2020.1757018","volume":"33","author":"MA El-Hamd","year":"2022","unstructured":"El-Hamd MA, El Saied ARA, Ahmed SH, Ibrahim HM, Hegazy EM (2022) Effect of narrow-band ultraviolet B phototherapy, methotrexate, and combined narrow-band ultraviolet B phototherapy with methotrexate on serum cathelicidin and vitamin D in patients with psoriasis vulgaris. J Dermatolog Treat 33(1):408\u2013414","journal-title":"J Dermatolog Treat"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-025-03801-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00403-025-03801-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-025-03801-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T05:07:18Z","timestamp":1738127238000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00403-025-03801-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,28]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3801"],"URL":"https:\/\/doi.org\/10.1007\/s00403-025-03801-2","relation":{},"ISSN":["1432-069X"],"issn-type":[{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,28]]},"assertion":[{"value":"6 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"316"}}